Previous Close | 116.80 |
Open | 117.10 |
Bid | 116.12 x 39400 |
Ask | 119.12 x 40000 |
Day's Range | 116.88 - 118.50 |
52 Week Range | 40.40 - 141.74 |
Volume | |
Avg. Volume | 879 |
Market Cap | 8.558B |
Beta (5Y Monthly) | 0.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The future of the weight loss market might not revolve around GLP-1 drugs.
Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s designed to work differently from those currently on the market and with the potential for fewer side effects.